KRRO Korro Bio Inc.

Price (delayed)

$41.91

Market cap

$30.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$83

Enterprise value

-$11.31M

frequency therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. through the controlled activation of progenitor cells, frequency enables disease modification without the ...

Highlights
Korro Bio's debt has plunged by 97% YoY and by 95% from the previous quarter
KRRO's EPS is up by 33% YoY and by 13% QoQ
Korro Bio's equity has plunged by 55% YoY and by 19% from the previous quarter
KRRO's quick ratio is down by 22% since the previous quarter and by 10% year-on-year

Key stats

What are the main financial stats of KRRO
Market
Shares outstanding
738,526
Market cap
$30.95M
Enterprise value
-$11.31M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.83
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$60.46M
EBITDA
-$55.4M
Free cash flow
-$43.02M
Per share
EPS
-$83
Free cash flow per share
-$58.25
Book value per share
$50.3
Revenue per share
$0
TBVPS
$62.77
Balance sheet
Total assets
$46.35M
Total liabilities
$9.61M
Debt
$1.43M
Equity
$36.74M
Working capital
$32.89M
Liquidity
Debt to equity
0.04
Current ratio
4.42
Quick ratio
4.55
Net debt/EBITDA
0.76
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-68.1%
Return on equity
-116%
Return on invested capital
-110.9%
Return on capital employed
-164.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KRRO stock price

How has the Korro Bio stock price performed over time
Intraday
4.31%
1 week
10.64%
1 month
19,257.97%
1 year
1,787.84%
YTD
988.57%
QTD
11,227.03%

Financial performance

How have Korro Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$63.2M
Net income
-$59.32M
Gross margin
N/A
Net margin
N/A
KRRO's net income is up by 31% year-on-year and by 12% since the previous quarter
KRRO's operating income is up by 27% year-on-year and by 11% since the previous quarter

Growth

What is Korro Bio's growth rate over time

Valuation

What is Korro Bio stock price valuation
P/E
N/A
P/B
0.83
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
KRRO's EPS is up by 33% YoY and by 13% QoQ
The stock's price to book (P/B) is 59% less than its 5-year quarterly average of 2.0 but 19% more than its last 4 quarters average of 0.7
Korro Bio's equity has plunged by 55% YoY and by 19% from the previous quarter

Efficiency

How efficient is Korro Bio business performance
KRRO's ROIC has plunged by 72% YoY and by 38% from the previous quarter
The return on equity has declined by 43% year-on-year and by 8% since the previous quarter
KRRO's return on assets is down by 26% year-on-year and by 11% since the previous quarter

Dividends

What is KRRO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KRRO.

Financial health

How did Korro Bio financials performed over time
KRRO's total liabilities has shrunk by 82% YoY and by 72% QoQ
The total assets has dropped by 66% year-on-year and by 42% since the previous quarter
Korro Bio's debt is 96% less than its equity
Korro Bio's debt has plunged by 97% YoY and by 95% from the previous quarter
KRRO's debt to equity has dropped by 93% since the previous quarter and by 93% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.